Concepedia

Publication | Closed Access

Paclitaxel, Estramustine Phosphate, and Carboplatin in Patients With Advanced Prostate Cancer

DOI

183

Citations

26

References

2001

Year

William Kevin Kelly, Tracy Curley, Susan F. Slovin, Glenn Heller, John McCaffrey, Dean F. Bajorin, Allison Ciolino, Kevin Regan, Morton K. Schwartz, Philip W. Kantoff,
Journal of Clinical Oncology

Abstract

TEC has significant antitumor activity and is well tolerated in patients with progressive androgen-independent prostate cancer.

References

YearCitations

Page 1